STEEL SECTOR | 3 | 2 | FUNDAMENTAL ANALYSIS | 5 | A | ECONOMY ANALYSIS | 6 | B | INDUSTRY ANALYSIS | 9 | C | COMPANY ANALYSIS * QUALITATIVE ANALYSIS * QUANTITATIVE ANALYSIS | 14 | 3 | CHART ANALYSIS AND INTERPRETATION | 31 | 4 | CONCLUSION AS PER COMPANY ANALYSIS | 35 | 5 | VALUATION OF COMPANY | 36 | 6 | INTREPRETATION & RECOMMENDATION | 43 | 7 | KEY TRIGGERS RELATED TO STEEL INDUSTRY | 44 | | BIBLOGRAPHY | 51 | | APPENDIX | 52 | STEEL SECTOR IN INDIA
Premium Steel
continuing value of the concept‚ both to strategic management research and practising managers. Methodology Critical review of the idea of strategic groups together with a practical strategic mapping illustration. Findings Strategic group theory still provides a useful approach for management research‚ which allows a detailed appraisal and comparison of company strategies within an industry. Research implications Strategic group research would undoubtedly benefit from more directly comparable‚ industry-specific
Premium Strategic management Management
Through this study‚ we have tried to compare and analyse the following 3 ratios for 5 pharmaceutical companies’ vis-à-vis the industry average for these ratios. 1. Debt-Equity ratio‚ 2. Current ratio‚ and 3. Interest coverage ratio The 5 companies analysed include: 1. Vivimed Labs 2. Anuh Pharma 3. Tonira Pharma 4. Lincoln Pharmaceuticals 5. Dishman Pharmaceuticals & Chemicals FACTS AND ASSUMPTIONS: As for the industry averages and industry best ratios‚ we have
Premium Pharmaceutical industry Pharmacology Pharmacy
divisions to produce and sell agrovet and pesticide products. It exports its products to Europe‚ Asia‚ Africa and South America. SQUARE Pharmaceuticals Limited (SPL) is the largest pharmaceutical company in Bangladesh and is leading the Pharmaceuticals sector from the very beginning. It has been continuously in the 1st position among all national and multinational companies since 1985. SPL offers a range of pharmaceutical products‚ which include alimentary preparations‚ anesthetics‚ antiallergy preparations
Premium Pharmaceutical industry Pharmacology
Table of Contents: Declaration Abstract Part I –Introduction Research Objective and justifications Report Outline Part-II Industry Description GSK-The Big Picture Factors for success in India References Part-III Literature review Chapter One –Merger: An Introduction 1.1 Introduction 1.2 The
Premium Mergers and acquisitions Pharmaceutical industry
CHAPTER: 1 INTRODUCTION History of Indian Pharma Industry The Pharmaceutical industry in India is the world ’s third-largest in terms of volume and stands 14th in terms of value. According to Department of Pharmaceuticals‚ Ministry of Chemicals and Fertilizers‚ the total turnover of India ’s pharmaceuticals industry between 2008 and September 2009 was US$21.04 billion. While the domestic market was worth US$ 12.26 billion. Sale of all types of medicines in the country is expected to
Premium Pharmaceutical industry Pharmacology Generic drug
an organization have the same objectives to achieve in the same time frame. There can be many such groups in an organization having their own group objectives. For Example: A medical device company can have a group‚ whose objective is to carry out research and development in a selected field of medicine. Whereas in the same company there is a group‚ whose objective is to market the medical device to a target population and another group whose objective is to ensure particular number of sales per month
Premium Human resource management Management Human resources
Glenmark Pharma Private Limited Case Study Introduction * The company is headquartered in Baroda. * Mr. Ranjit Deshmukh holds the position of the Vice President. * Plants set up in Tamilnadu‚ Hyderabad and Gurgaon. * Markets bulk and cancer drugs and formulations. * Strong sales force of 700 people‚ supervised by 85 sales managers. * Salespeople have to compete with multiple competitors in different markets. * Competitors are from local manufacturers to large multinationals
Premium Management Sales Maslow's hierarchy of needs
Security Analysis and Portfolio Management Equity Research Report – Shalimar Paints Industry Overview: Indian Paint Industry is today worth INR 275 bn. with ~69 % coming from organized segment and rest coming from unorganized segment. India has one of the lowest per-capita consumption of paints at just 1.5 kg. (World Average = 8 kg.) because of which Indian Paint Industry is projected to sustain its growth momentum to reach ~460 bn. by 2016. Organized segment is a very concentrated
Premium Asset Capacity utilization Balance sheet
1 India Equity Research | IT Sector Update IT Infosys versus TCS FY09 annual report analysis: Ten conclusions TCS and Infosys have been compared on financial performance quarter after quarter. Needless to mention‚ there are several key operational parameters that have driven their performance over the years. Some of them are shortterm measures towards achieving long-terms goals‚ such as: (1) investments in research and development (R&D)‚ patents and non-linear growth Kunal Sangoi +91-22-6623
Premium Annual report Financial statements Infosys